These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7603173)

  • 1. Bone-marrow transplantation.
    Magrath I
    Lancet; 1995 Jul; 346(8966):59-60. PubMed ID: 7603173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
    Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of natural cytotoxicity after bone marrow transplantation.
    Lange A; Jazwiec B; Tomaszewska-Toporska B; Toporski J
    Immunol Invest; 1991 Apr; 20(2):207-13. PubMed ID: 1830864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful HLA-identical unrelated allogeneic bone marrow transplantation with a very low dose of stem cells for a patient with chronic myeloid leukemia in blast crisis.
    Arai H; Arai Y; Haraguchi K; Nakamura Y; Tsurumi S; Maki K; Aoyagi A; Nakamura Y; Saito K; Mitani K
    Leuk Lymphoma; 2002 Oct; 43(10):2067-9. PubMed ID: 12481912
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG).
    Hirabayashi N; Kodera Y; Matsuyama T; Tanimoto M; Horibe K; Naoe T; Kojima H; Yamada H; Utsumi M; Morishima Y
    Transplant Proc; 1995 Feb; 27(1):1380-2. PubMed ID: 7878920
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation for leukaemia: a lame stalking horse for use of high-technology medical care.
    Magrath I
    Lancet; 1995 Mar; 345(8950):601-2. PubMed ID: 7898174
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor leucocyte infusions for relapse in chronic myelogenous leukaemia.
    Kumar L
    Lancet; 1994 Oct; 344(8930):1101-2. PubMed ID: 7934489
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy.
    Rettinger E; Huenecke S; Bonig H; Merker M; Jarisch A; Soerensen J; Willasch A; Bug G; Schulz A; Klingebiel T; Bader P
    Haematologica; 2016 Apr; 101(4):e153-6. PubMed ID: 26768688
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
    Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
    Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ph+ acute myelogenous leukemia with t(7;11)(p15;p15) and clonal evolution in relapse after bone marrow transplantation.
    Miura I; Nishinari T; Hashimoto K; Nimura T; Takatsu H; Niitsu H; Hirokawa M; Kuwayama A; Nishimura S; Miura AB
    Acta Haematol; 1993; 90(3):148-50. PubMed ID: 8291375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
    Hiraoka A; Shibata H; Masaoka T
    Transplant Proc; 1992 Dec; 24(6):3047-8. PubMed ID: 1466051
    [No Abstract]   [Full Text] [Related]  

  • 17. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of bone marrow transplantation in the treatment of leukemia].
    Robak T
    Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation at The Mount Sinai Hospital.
    Fruchtman SM; Scigliano E; Ross V; Abramowitz A; Lipton J; Mandell L; Shank B
    Mt Sinai J Med; 1994 Jan; 61(1):3-12. PubMed ID: 8183289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.